CALEC surgery, or cultivated autologous limbal epithelial cell therapy, represents a groundbreaking advancement in the field of corneal repair, offering new hope for patients with irreversible eye damage.This innovative procedure, pioneered at Mass Eye and Ear, involves the extraction of stem cells from a healthy eye and their transformation into a graft that can restore the corneal surface in affected individuals.